105 related articles for article (PubMed ID: 26038517)
1. Co-infection of visceral leishmaniasis and HIV-1: a surviving case in China and review of treatment strategies.
Song S; Gui X; Guan L
Emerg Microbes Infect; 2014 Apr; 3(4):e24. PubMed ID: 26038517
[TBL] [Abstract][Full Text] [Related]
2. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
3. The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.
López-Vélez R
Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():143-7. PubMed ID: 14678641
[TBL] [Abstract][Full Text] [Related]
4. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN
Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852
[TBL] [Abstract][Full Text] [Related]
5. Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.
Mahajan R; Das P; Isaakidis P; Sunyoto T; Sagili KD; Lima MA; Mitra G; Kumar D; Pandey K; Van Geertruyden JP; Boelaert M; Burza S
Clin Infect Dis; 2015 Oct; 61(8):1255-62. PubMed ID: 26129756
[TBL] [Abstract][Full Text] [Related]
6. Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
Ritmeijer K; ter Horst R; Chane S; Aderie EM; Piening T; Collin SM; Davidson RN
Clin Infect Dis; 2011 Dec; 53(12):e152-8. PubMed ID: 22016502
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological patterns of mortality due to visceral leishmaniasis and HIV/AIDS co-infection in Brazil, 2000-2011.
Martins-Melo FR; Lima Mda S; Alencar CH; Ramos AN; Heukelbach J
Trans R Soc Trop Med Hyg; 2014 Jun; 108(6):338-47. PubMed ID: 24706340
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia.
Hurissa Z; Gebre-Silassie S; Hailu W; Tefera T; Lalloo DG; Cuevas LE; Hailu A
Trop Med Int Health; 2010 Jul; 15(7):848-55. PubMed ID: 20487426
[TBL] [Abstract][Full Text] [Related]
10. Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.
Standaert D; Laurent F; Jonckheere S; Scheiff JM; Vandercam B; Yombi JC
Acta Clin Belg; 2013; 68(2):124-7. PubMed ID: 23967722
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
[TBL] [Abstract][Full Text] [Related]
12. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
[TBL] [Abstract][Full Text] [Related]
13. Post-kala-azar dermal leishmaniasis in HIV-infected patients with AIDS: a report of two cases diagnosed in the USA.
Farooq U; Choudhary S; Chacon AH; Lebrun E; Shiman MI; Hernandez J; Milikowski C; Kerdel FA; Romanelli P
Int J Dermatol; 2013 Sep; 52(9):1098-104. PubMed ID: 23834626
[TBL] [Abstract][Full Text] [Related]
14. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Mira JA; Corzo JE; Rivero A; Macias J; De Leon FL; Torre-Cisneros J; Gomez-Mateos J; Jurado R; Pineda JA
Am J Trop Med Hyg; 2004 Mar; 70(3):298-301. PubMed ID: 15031520
[TBL] [Abstract][Full Text] [Related]
15. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of human immunodeficiency virus-visceral leishmaniasis-co-infection.
Naufal Spir PR; Zampieri D'Andrea LA; Fonseca ES; Prestes-Carneiro LE
J Microbiol Immunol Infect; 2016 Apr; 49(2):295-9. PubMed ID: 23834783
[TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
Salih NA; van Griensven J; Chappuis F; Antierens A; Mumina A; Hammam O; Boulle P; Alirol E; Alnour M; Elhag MS; Manzi M; Kizito W; Zachariah R
Trop Med Int Health; 2014 Feb; 19(2):146-52. PubMed ID: 24433217
[TBL] [Abstract][Full Text] [Related]
18. A case report and literature review: diagnosis and treatment of human immunodeficiency virus coinfected with visceral leishmania by metagenomic next-generation sequencing in China.
Tang C; He S; Wang N; Chen L
Ann Transl Med; 2022 Apr; 10(8):497. PubMed ID: 35571385
[TBL] [Abstract][Full Text] [Related]
19. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
20. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
